Art

J-GLOBAL ID：200902015729937567   Reference number：92A0584383

Reevaluation of Ifosfamide in Patients with Non-small Cell Lung Cancer.

非-小細胞肺癌患者でのイホスファミドの再評価

Author (9)： KASHIMA N (Showa Univ. Medicine, Tokyo, JPN) ,  ISHIHARA J (Showa Univ. Medicine, Tokyo, JPN) ,  TAZAWA H (Showa Univ. Medicine, Tokyo, JPN) ,  NOGUCHI H (Showa Univ. Medicine, Tokyo, JPN) ,  HIRAIZUMI T (Showa Univ. Medicine, Tokyo, JPN) ,  HORICHI N (Showa Univ. Medicine, Tokyo, JPN) ,  SATO I (Showa Univ. Medicine, Tokyo, JPN) ,  OHMORI T (Showa Univ. Medicine, Tokyo, JPN) ,  SASAKI Y (National Cancer Center Hospital East, Kashiwa, JPN)
Material： Showa University Journal of Medical Sciences  (Showa Univ J Med Sci)
Volume： 4  Issue： 1  Page： 37-40  Publication year： Jun. 1992 
JST Material Number： L1154A  ISSN： 0915-6380  CODEN： SUMSEG  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： clinical trial ,...
Semi thesaurus term： lung cancer ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=92A0584383&from=J-GLOBAL&jstjournalNo=L1154A") }}

JST classification (2)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (2)： Mesna ,  Ifosfamide

Reference (10)：

• 1) Costanzi JJ, Gangliano R, Loukas D, Frank J, Panettiere J and Hokanson A: Ifosfamide in the treatment of recurrent or disseminated lung cancer. A phase II study of two dose schedules. Cancer, 41: 1715-1719 (1978)
• 2) Costanzi JJ, Mogan LR and Hokanson JA: Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung. Semiri Oncol, 9 (suppl 1) : 61-65 (1982)
• 3) Harrison EF, Hawke JE, Hunter HL, Costanzi JJ, Morgan LR, Plotokin D, Tucker WG and Worrall PM: Single dose ifosfamide: effigy studies in non-small cell lung cancer. Semin Oncol, 9 (suppl 1) : 56-60 (1982)
• 4) Morgan LR, Posey LE, Rainey J, Bickers J, Ryan D, Vial R, Hull EW et al: Ifosfamide: A weekly dose fractionated schedule in bronchogenic carcinoma. Cancer Treat Rep, 65: 693-695 (1981)
• 5) Nobile MT, Rosso R and Brema F: Phase II study of ifosfamide combined with mesna uroprotection in advanced non-small cell carcoinoma and other solid tumors. Tumori, 70: 433-437 (1984)

Terms in the title (4)： 小細胞肺癌 ,  患者 ,  イホスファミド ,  評価